Categories: Wire Stories

TheraVet Strengthens Its Intellectual Property With the Issuance of a Patent on VISCO-VET Technology in Europe, Israël & Singapore

GOSSELIES, Wallonia, Belgium–(BUSINESS WIRE)–Regulatory News:


TheraVet (ISIN: BE0974387194 – ticker: ALVET), a pioneering company in the management of osteoarticular diseases in pets, announces that the European Patent Office (EPO), and the Singapore and Israel patent offices granted a patent covering TheraVet VISCO-VET technology.

This patent, running until 2040, covers the manufacturing process of a gel-forming composition as well as the composition obtained by the said method. Patent applications with the same subject matter are pending in the United States, China, Japan and other territories. Two other patent applications on the VISCO-VET technology are currently under examination.

VISCO-VET is a veterinary medicinal product currently under clinical assessment in a prospective, multicentric, controlled, double-blinded, randomized field study in client-owned dogs suffering from osteoarthritis (OA). This study aims to evaluate the potential of a unique intra-articular injection of VISCO-VET in stifle or elbow – with a focus on elbow – to improve dog’s mobility and reduce pain compared to a non-treated control group.

Enrico Bastianelli, Chief Executive Officer of TheraVet, states: “We are pleased that our efforts to strengthen our intellectual property have resulted in the issuance of this key patent on VISCO-VET technology. We are continuing our initiatives to protect our technologies in other main territories and also through other patent families that are still pending.”

About TheraVet SA

TheraVet is a veterinary biotechnology company specializing in osteoarticular treatments for companion animals. The Company develops targeted, safe and effective treatments to improve the quality of life of pets suffering from joint and bone diseases. For pet owners, the health of their pets is a major concern and TheraVet’s mission is to address the need for innovative and curative treatments. TheraVet works closely with international opinion leaders in order to provide a more effective response to ever-growing needs in the field of veterinary medicine. TheraVet is listed on Euronext Growth® Paris and Brussels, has its head office in Belgium (Gosselies) with a US subsidiary.

For more information, visit the TheraVet website or follow us on LinkedIn / Facebook / Twitter

Contacts

TheraVet
Chief Operating Officer

Sabrina Ena

investors@thera.vet
Tel: +32 (0) 71 96 00 43

NewCap
Investor Relations and Financial Communications

Théo Martin / Nicolas Fossiez

theravet@newcap.eu
Tel: +33 (0)1 44 71 94 94

Press Relations

Arthur Rouillé

theravet@newcap.eu
Tel: +33 (0)1 44 71 00 15

NewCap Belgique
Press Relations

Laure-Eve Monfort

lemonfort@thera.vet
Tel: + 32 (0) 489 57 76 52

Alex

Recent Posts

FWD Online Insurance Platform [1] launches Easy WealthPlus Endowment Plan Offers 8-year guaranteed return of up to 4.53% p.a. Fully online application process doable in as quick as five minutes

Supporting customers’ medium-term saving goals; offering 105%2 life protection on single premium paid without any…

40 mins ago

Germany’s VDMA Robotics and Automation Halves Growth Forecast – Positive Signs From International Business

Decline in incoming orders from Germany Increased competition from China FRANKFURT, Germany--(BUSINESS WIRE)--Robotics and automation…

1 hour ago

Shaping the Future: Revomed Invests Over 100 Million Baht in Innovative Research to Lead Marketing in the Modern Health and Beauty Business

BANGKOK, THAILAND - Media OutReach Newswire - 17 June 2024 - Revomed Group Company Limited,…

2 hours ago

KAYTUS Support for Intel® Xeon® 6 Processors – Unmatched AI Performance and Eco-Efficiency

Meeting the Growing Demand for Computing Power in the Era of AI with 230% Performance…

3 hours ago

Gogoro Strategic Profile: The Taiwan-Based Global Leader in the E2W Battery-Swapping Ecosystem – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Strategic Profiling of Gogoro Inc" report has been added to ResearchAndMarkets.com's offering. Gogoro…

3 hours ago

Vectron Systems AG: Statement Takeover Offer English Version

MÜNSTER, GERMANY - EQS Newswire - 17 June 2024 - The business combination announced on…

4 hours ago